Valeant to bring looser terms in $5.3bn refinancing
After releasing first quarter results, Canadian drugmaker Valeant is again looking to refinance old debt with less restrictive facilities, announcing a new $5.3bn refinancing package on Thursday.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: